scholarly article | Q13442814 |
P356 | DOI | 10.1093/INFDIS/JIV342 |
P698 | PubMed publication ID | 26123561 |
P50 | author | Allison L. Naleway | Q37377682 |
Elizabeth R. Unger | Q41636563 | ||
Sheila Weinmann | Q89443286 | ||
Lauri E Markowitz | Q96186181 | ||
Martin Steinau | Q114417639 | ||
P2093 | author name string | Eileen F Dunne | |
Ning Smith | |||
Jim Braxton | |||
Bradley Crane | |||
P2860 | cites work | Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study | Q28245583 |
Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction | Q36128894 | ||
Reduction of HPV infections through vaccination among at-risk urban adolescents | Q36176699 | ||
Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England | Q37503936 | ||
Post-licensure monitoring of HPV vaccine in the United States | Q37699644 | ||
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis | Q38037763 | ||
Population impact of HPV vaccines: summary of early evidence | Q38164983 | ||
Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact | Q45077291 | ||
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. | Q45251131 | ||
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. | Q51871950 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cervix uterine cancer | Q160105 |
HPV vaccine | Q900189 | ||
P304 | page(s) | 1970-1975 | |
P577 | publication date | 2015-06-29 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013. | |
P478 | volume | 212 |
Q47921143 | Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. |
Q92499094 | Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination |
Q97565439 | Evidence of HPV vaccination efficacy comes from more than clinical trials |
Q59349018 | Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program |
Q38671633 | Functional assessment and structural basis of antibody binding to human papillomavirus capsid |
Q57463921 | Human Papillomavirus Prevalence Among American Indian Women of the Great Plains |
Q47257772 | Impact of HPV vaccination with Gardasil® in Switzerland |
Q50091385 | Monitoring the impact of HPV vaccine in males-Considerations and challenges |
Q37288157 | Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes |
Q78879005 | Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis |
Q36987575 | The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis |
Q64136607 | Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015 |
Search more.